🇺🇸 Naltrexone Pill in United States
3 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 22 April 2025 – 22 April 2026
- Total reports: 3
Most-reported reactions
- Injection Site Mass — 1 report (33.33%)
- Memory Impairment — 1 report (33.33%)
- Wrong Technique In Product Usage Process — 1 report (33.33%)
Other Psychiatry / Addiction Medicine approved in United States
Frequently asked questions
Is Naltrexone Pill approved in United States?
Naltrexone Pill does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Naltrexone Pill in United States?
Albert Einstein Healthcare Network is the originator. The local marketing authorisation holder may differ — check the official source linked above.